Concepedia
Statistics
Publications
3
Citations
39
H-Index
Active since
2014
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)
Tun-Ying Hsu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States).
Publications per year
2014–2017
Cost–effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal
P.A. Laires, Flavia Ejzykowicz, Tun-Ying Hsu et al. · Journal of Medical Economics · 2015 · 15 citations
Cost-Effectiveness of Boceprevir Co-Administration versus Pegylated Interferon-α2b and Ribavirin Only for Patients with Hepatitis C Genotype 1 in Singapore
Yock Young Dan, Shannon Ferrante, Elamin H. Elbasha et al. · Antiviral Therapy · 2014 · 14 citations
The clinical and economic benefits of school-based quadrivalent HPV vaccination in Singapore
Sun Kuie Tay, Tun-Ying Hsu, A. V. Shcheprov et al. · International Journal of Gynecology & Obstetrics · 2017 · 10 citations
1–3 of 3